Mediclinic completes R5bn rights issue
Mediclinic’s R5bn ($568m) rights issue was 99.7% subscribed, the company said on Monday. The South African private healthcare company, which is listed on the Johannesburg Stock Exchange, will use proceeds from the deal to support a R28bn loan refinancing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts